Evidence map›Paper›PMID 29631587›Full record

ArticleBMC health services research2018

Evaluation of the implementation of a clinical pharmacy service on an acute internal medicine ward in Italy.

Nicola Lombardi, Li Wei, Maisoon Ghaleb, Enrico Pasut, Silvia Leschiutta, Paolo Rossi, Maria Grazia Troncon

Abstract read
In one paragraph

Article in BMC health services research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Impact of medical and pharmaceutical interventions on anti-infective prescriptions: an observational study.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2022
    Observational
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nicola LombardiDepartment of Pharmacy, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, Cambridgeshire, CB2 0QQ, UK. n.lombardi@outlook.com.
Li WeiDepartment of Pharmacy Practice and Policy, University College London School of Pharmacy, 29-39 Brunswick Square, Bloomsbury, London, WC1N 1AX, UK.
Maisoon GhalebSchool of Life and Medical Science, Department of Pharmacy, Pharmacology & Postgraduate Medicine, University of Hertfordshire, Hatfield, Hertfordshire, AL10 9AB, UK.
Enrico PasutDepartment of Pharmacy, Azienda Sanitaria Universitaria Integrata di Udine, Via Pozzuolo, 330-33100, Udine, Friuli Venezia Giulia, Italy.
Silvia LeschiuttaDepartment of Pharmacy, Azienda Sanitaria Universitaria Integrata di Udine, Via Pozzuolo, 330-33100, Udine, Friuli Venezia Giulia, Italy.
Paolo RossiDivision of Internal Medicine, Azienda Sanitaria Universitaria Integrata di Udine, Via Pozzuolo, 330 - 33100, Udine, Friuli Venezia Giulia, Italy.
Maria Grazia TronconDepartment of Pharmacy, Azienda Sanitaria Universitaria Integrata di Udine, Via Pozzuolo, 330-33100, Udine, Friuli Venezia Giulia, Italy.

Funding

Medical Research Council G106/1249
6 · The paper itself

Abstract

backgroundSuccessful implementation of clinical pharmacy services is associated with improvement of appropriateness of prescribing. Both high clinical significance of pharmacist interventions and their high acceptance rate mean that potential harm to patients could be avoided. Evidence shows that low acceptance rate of pharmacist interventions can be associated with lack of communication between pharmacists and the rest of the healthcare team. The objective of this study was to evaluate the effect of a structured communication strategy on acceptance rate of interventions made by a clinical pharmacist implementing a ward-based clinical pharmacy service targeting elderly patients at high risk of drug-related problems. Characteristics of interventions made to improve appropriateness of prescribing, their clinical significance and intervention acceptance rate by doctors were recorded.

methodsA clinical pharmacy intervention study was conducted between September 2013 and December 2013 in an internal medicine ward of a teaching hospital. A trained clinical pharmacist provided pharmaceutical care to 94 patients aged over 70 years. The clinical pharmacist used the following communication and marketing tools to implement the service described: Strengths, Weaknesses, Opportunities and Threats (SWOT) analysis; Specific, Measurable, Achievable, Realistic and Timely (SMART) goals; Awareness, Interest, Desire, Action (AIDA) model.

resultsA total of 740 interventions were made by the clinical pharmacist. The most common drug classes involved in interventions were: antibacterials for systemic use (11.1%) and anti-parkinson drugs (10.8%). The main drug-related problem categories triggering interventions were: no specific problem (15.9%) and prescription writing error (12.0%). A total of 93.2% of interventions were fully accepted by physicians. After assessment by an external panel 63.2% of interventions (96 interventions/ per month) were considered of moderate clinical significance and 23.4% (36 interventions/ per month) of major clinical significance. The most frequent interventions were to educate a healthcare professional (20.4%) and change dose (16.1%).

conclusionsTo our knowledge this is the first study evaluating the effect of a structured communication strategy on acceptance rate of pharmacist interventions. Pharmaceutical care delivered by the clinical pharmacist is likely to have had beneficial outcomes. Clinical pharmacy services like the one described should be implemented widely to increase patient safety.

Indexed as

Internal MedicineAgedAnti-Bacterial AgentsAntiparkinson AgentsAttitude of Health PersonnelClinical Pharmacy Information SystemsDrug-Related Side Effects and Adverse ReactionsFemaleHealth Services for the AgedHealth Services ResearchHumansItalyMaleMedication ErrorsMiddle AgedPharmacistsAnti-Bacterial AgentsAntiparkinson AgentsClinical pharmacistCommunicationDrug-related problemsElderlyPharmaceutical care

Identifiers

PMID29631587
PMCPMC5891983

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.